Invention Grant
- Patent Title: CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivity
-
Application No.: US17275880Application Date: 2019-09-11
-
Publication No.: US11944691B2Publication Date: 2024-04-02
- Inventor: Theresa Osl , Hans-Jürgen Wester , Margret Schottelius , Tobias Kapp , Horst Kessler
- Applicant: TECHNISCHE UNIVERSITÄT MÜNCHEN
- Applicant Address: DE Munich
- Assignee: TECHNISCHE UNIVERSITÄT MÜNCHEN
- Current Assignee: TECHNISCHE UNIVERSITÄT MÜNCHEN
- Current Assignee Address: DE Munich
- Agency: Parker Highlander PLLC
- Priority: EP 194124 2018.09.12
- International Application: PCT/EP2019/074196 2019.09.11
- International Announcement: WO2020/053256A 2020.03.19
- Date entered country: 2021-03-12
- Main IPC: A61K51/08
- IPC: A61K51/08
Abstract:
The present disclosure relates to imaging and endoradiotherapy of diseases involving chemokine receptor 4 (CXCR4). Provided are compounds which bind or inhibit hCXCR4 and mCXCR4 and furthermore carry at least one moiety which is amenable to labeling. Provided are also medical uses of such compounds.
Information query
